Science for Brazil (Reino Unido)

Chemical Probes Conference

Publicado em 05 março 2014

The use of chemical probes in human and plant biology is a fast emerging area of science set to come under the spotlight at an international conference hosted by Brazil at the University of Campinas April 28-29th.

This 2-day conference will showcase the latest advances in discovery, design and application of Chemical Probes in human and plant biology – and how ensuring that these molecules are made available with no restrictions on use accelerates innovation in previously uncharted pathways and processes.

The conference is called Chemical Probe-based Open Science: Uncovering New Human and Plant Biology, presented by the Structural Genomics Consortium (SGC) and Natureconferences and funded by the São Paulo Research Foundation (FAPESP).

World-leading experts in this exciting field from Brazil and abroad will share their experiences with the wider scientific community. This conference represents a unique opportunity to encourage the development of Open Access Chemical Biology and Medicinal Chemistry in Brazil and other parts of World.

“Biochemistry focuses on identifying molecules that connect to very well-defined targets – in other words, proteins – in order to manipulate and make use of human and plant biological systems. One important group of proteins widely used in the pharmaceutical industry are signalling proteins, such as kinases,” said Paulo Arruda, Unicamp researcher and event organizer.

An important objective of the conference, said Arruda, is to foster Open Innovation, or the free sharing of discoveries of new molecules with the entire interested academic community, unhindered by patents.

Among the speakers already confirmed are Brazilian and foreign researchers and leaders associated with Oxford University, the University of Toronto, the University of California (United States), FAPESP, Unicamp, the National Council for Scientific and Technological Development (CNPq) and companies such as Pfizer, GlaxoSmithKline, Bayer CropSciences, Takeda Pharmaceuticals and Monsanto.

You can read a full article by Brazilian journalist Noêmia Lopes by clicking here

You can find information from Nature Publishing Group by clicking here.